Founded in 2006
Financial data: €51.52M Total Raised (as of 01/2016)
F-star is a clinical-stage company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer.
Moneta B280 Babraham Research Campus Cambridge, CB22 3AT
Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech
From The Clinic
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Deals & Finance
UK biotech is catching up to the US, but will it run out of gas?
The 15 Best Biotech Incubators in Europe, Hatching Future Biotech Stars
Video from LaBiotechTour.com
Watch entire documentaries »
Labiotech UG, All Rights Reserved -
Send this to friend